Sudeep Pharma Stock: price and insider trades · India
Sudeep Pharma: what insiders have been doing
Sudeep Pharma is a listed company. Its insiders report their share dealings to SEBI (PIT + SAST). Between 8 November 2025 and 8 November 2026, 2 insiders published 2 filings.
There is no open-market purchase to report; the filings show 1 sale by 1 insider. The totals exclude 1 filing filed without an amount.
Compared with its exchange (1,984 companies, median 4 filings), a count of 2 filings is below the norm. Since 2026, the database holds no purchases and 1 sale by insiders of the company.
Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.
Who traded when
BuySaleAnalyst consensus: bullish or bearish?
Analysts rate Sudeep Pharma Underperform (bearish), based on 2 analysts. Average price target: ₹988.00.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 2,668,118 shares-MarketSEBI:ca869cc27a3dd64bcbca093497d5d509d90bb40d
- 9,451,295 shares-Pref. AllotmentSEBI:044b979436d31588976df29b4ad518690806bfd2
2 of 2 declarations
About Sudeep Pharma
Sudeep Pharma is a company operating in the XBOM market, specializing in the pharmaceutical sector. It focuses on the research, development, and marketing of pharmaceutical products.